Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
“According to BCC Research, the global market is projected to grow from $932.8 million in 2024 to $2.7 billion by 2030, driven by telemedicine, remote monitoring and secure patient data needs.”
May 19, 2026
The global biometrics as a service in medical devices market is projected to surge from $932.8 million in 2024 to $2.7 billion by 2030, representing a robust compound annual growth rate of 19.1% during the forecast period, according to a new report from BCC Research titled Biometrics as a Service in Medical Devices: Global Markets.
KEY FINDINGS
Market Growth: The biometrics as a service in medical devices market will expand at a 19.1% CAGR through 2030, driven primarily by the accelerating adoption of remote patient monitoring and telemedicine solutions.
Regional Leadership: North America commands the largest market share at 43.5%, supported by advanced healthcare infrastructure, high technology adoption rates, and established regulatory frameworks for digital health solutions.
Digital Health Integration: Growing integration of biometric systems into virtual consultations and telehealth platforms is creating new revenue streams as healthcare providers seek secure, contactless patient verification methods.
Chronic Disease Management: The rising prevalence of chronic lifestyle diseases requiring continuous monitoring is fueling demand for biometric-enabled medical devices.
Security Imperative: Increasing emphasis on secure patient data handling and regulatory compliance is driving healthcare organizations to implement biometric authentication systems.
Competitive Landscape: Key market players include NEC Corp., BIO-Key International, Fujitsu, HID Global Corp., Aware Inc., Imprivata Inc., IDEMIA, LifeQ Global Ltd., Aratek, and Spectra Technovision (India) Pvt. Ltd.
MARKET DRIVERS
The convergence of several structural forces is propelling market expansion. The COVID-19 pandemic fundamentally accelerated the adoption of telehealth solutions, creating sustained demand for biometric systems that can securely verify patient identities during virtual consultations. Simultaneously, the growing burden of chronic diseases such as diabetes, cardiovascular conditions, and respiratory disorders is driving healthcare providers to implement continuous monitoring solutions.
INVESTMENT CONSIDERATIONS
The biometrics as a service model presents compelling investment opportunities as it reduces upfront capital expenditure for healthcare providers while offering recurring revenue streams for technology vendors. Companies positioned at the intersection of AI-powered biometric analysis, advanced wearable sensors, and multimodal authentication systems are best positioned to capture market share.
For more information or to download the report, visit https://www.bccresearch.com/market-research/biotechnology/biometrics-as-a-service-in-medical-devices-markets.html
Biometrics as a Service in Medical Devices: Global Markets( BIO276A )
Publish Date: Apr 2026
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum